Neurobiology and Neurologic Disease
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the treatment of neurobiology and neurologic diseases. Topics include, but are not limited to neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Emerging Research in Neurorehabilitation (Deadline: 15 October 2023)
- Amyloid Pathology: Cellular Mechanism and Therapy Targets (Deadline: 16 October 2023)
- Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry (Deadline: 31 October 2023)
- Pathogenesis and Therapy of Neurovascular Compression Syndromes (Deadline: 31 October 2023)
- Molecular Research of Alzheimer's Disease 2.0 (Deadline: 31 October 2023)
- Advances in Pheochromocytoma and Paraganglioma 2.0 (Deadline: 31 October 2023)
- Dopamine in Health and Disease 2.0 (Deadline: 31 October 2023)
- Editorial Board Members’ Collection Series: “Amyotrophic Lateral Sclerosis: The Present and the Future of the Research” (Deadline: 31 October 2023)
- Amyloid β, Tau, and α-Synuclein Aggregates in the Pathogenesis, Prognosis, and Therapeutics for Neurodegenerative Diseases (Deadline: 31 October 2023)
- Application of Animal Models and New Therapeutic Approaches in Neurological Diseases (Deadline: 31 October 2023)
- Dualistic Equilibrium in Neurotransmission and Beyond: Unraveling the Pathophysiology and Unlocking Novel Therapeutic Targets in Neuropsychiatric Disorders (Deadline: 31 October 2023)
- Emerging Trends in Brain Stimulation (Deadline: 31 October 2023)
- Genetic Architecture of Dementia (Deadline: 31 October 2023)
- Neuroimaging: Current Position and Future Directions (Deadline: 15 November 2023)
- Early Diagnosis Research of Inherited Neuropathies (Deadline: 16 November 2023)
- Spinal Cord Injury and Inflammation (Deadline: 30 November 2023)
- Tauopathies: New Perspectives and Challenges (Deadline: 30 November 2023)
- Biomarkers of Parkinson’s Disease (Deadline: 30 November 2023)
- Advances in Targeted Therapy of Neuroblastoma (Deadline: 30 November 2023)
- Biomarkers in Neurological Disorders (Deadline: 30 November 2023)
- Molecular Mechanisms and Treatment of Alzheimer’s Disease (Deadline: 30 November 2023)
- Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease Volume II (Deadline: 30 November 2023)
- Epigenetic Mechanisms of Postoperative Cognitive Impairment Induced by Anesthesia and Neuroinflammation (Deadline: 30 November 2023)
- Molecular Mechanisms of Neurological Autoimmune Disorders Volume II (Deadline: 30 November 2023)
- Advanced Research in Peripheral Nerve Regeneration (Deadline: 30 November 2023)
- Imaging Studies on Neurological Diseases (Deadline: 30 November 2023)
- Mechanistic Insights of Selective Autophagy in Neurodegenerative Diseases (Deadline: 30 November 2023)
- Aging and Neuroendocrinological Diseases (Deadline: 30 November 2023)
- Brain Imaging and Cognitive Deficits in Psychiatric Disorders (Deadline: 30 November 2023)
- Beta Amyloid: Synaptic Regulation and Dysregulation (Deadline: 30 November 2023)
- Advances in Pharmacotherapy of Alzheimer’s Disease (Deadline: 30 November 2023)
- Drug Targets and Associated Therapeutic Treatments for Parkinson's Disease (Deadline: 30 November 2023)
- New Insights in Aneurysmal Subarachnoid Hemorrhage Pathogenesis and Its Impact on Outcome and Treatment (Deadline: 30 November 2023)
- Recent Advances in Brain Vascular Diseases Management and Therapy 2.0 (Deadline: 30 November 2023)
- Purinergic Signaling in Cerebral Ischemia and Other Brain Diseases (Deadline: 30 November 2023)
- Small Extracellular Vesicles: A Novel Avenue for Brain Tumor Management 2.0 (Deadline: 30 November 2023)
- Ferroptosis Pathways in Neurodegenerative and Neuropsychiatric Diseases (Deadline: 15 December 2023)
- Neuromodulation: From Theories to Therapies (Deadline: 15 December 2023)
- New Perspectives on Neuronal Cytoskeletal Dysregulation in Health and Disease (Deadline: 20 December 2023)
- Acute Ischemic Stroke: From Imaging Diagnosis to the Latest Treatment Strategy (Deadline: 30 December 2023)
- Research Advances in Brain Metastasis (Deadline: 31 December 2023)
- Neuropeptides in Biomedicines 2.0 (Deadline: 31 December 2023)
- Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach 3.0 (Deadline: 31 December 2023)
- Glycine-(and D-Serine)-Related Neurotransmission: Promising Therapeutic Targets with Still Unsolved Problems (Deadline: 31 December 2023)
- Emerging Trends in Neurodegenerative Diseases (Deadline: 31 December 2023)
- Biomarkers of Traumatic Brain Injury (Deadline: 31 December 2023)
- New Insights into Motor Neuron Diseases (Deadline: 31 December 2023)
- Probing the Role of Alzheimer’s Disease Risk Gene Using Human-Induced Pluripotent Stem Cells and Transgenic Animal Models (Deadline: 31 December 2023)
- Synaptic Transmission: From Molecular to Neural Network Levels 2.0 (Deadline: 31 December 2023)
- Advancements in Antipsychotics (Deadline: 31 December 2023)
- Neuropathic Pain: From Mechanisms to Therapeutic Approaches (Deadline: 31 December 2023)
- 10th Anniversary of Biomedicines—Novel Targets for Cranial Tumors (Deadline: 31 December 2023)
- Small RNA Signatures in Neurological Disorders: Insights from Developmental Biology and Neuroscience (Deadline: 31 December 2023)
- Neuroinflammation: From Pathophysiologic Mechanisms to Therapeutic Strategies (Deadline: 31 December 2023)
- Novel Diagnostic and Therapeutic Strategy for Neurodegenerative Diseases (Deadline: 31 December 2023)
- Pharmacological Targets for Neuroinflammation (Deadline: 15 January 2024)
- Emerging Trends in Neurostimulation and Neuromodulation Research (Deadline: 31 January 2024)
- Artificial Intelligence in Neurobiology and Neurologic Diseases (Deadline: 31 January 2024)
- Crosstalk between Depression, Anxiety, Dementia, and Chronic Pain: Comorbidity in Behavioral Neurology and Neuropsychiatry Volume III (Deadline: 31 January 2024)
- Molecular Genetics of Psychiatric Pathology (Deadline: 31 January 2024)
- New Molecular Insights into the Pathogenesis and Drug Development of Neurodegenerative Diseases (Deadline: 31 January 2024)
- Recent Therapeutic Advances in Parkinson’s Disease (Deadline: 31 January 2024)
- Neuroendocrine Neoplasia: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 January 2024)
- Advanced Research in Stroke (Deadline: 31 January 2024)
- Alzheimer's Disease—115 Years after Its Discovery 2.0 (Deadline: 31 January 2024)
- Parkinson’s Disease: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 January 2024)
- The Neurotoxicity of Biomedicines (Deadline: 31 January 2024)
- Neuromodulation from Theory to Therapy Volume II (Deadline: 31 January 2024)
- Pain–Neuroinflammation Dyad: New Therapeutic Strategies or Pharmacological Targets to Counter Them (Deadline: 31 January 2024)
- Recent Advances in Craniofacial Pain and Headaches (Deadline: 31 January 2024)
- Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases (Deadline: 29 February 2024)
- Biomarkers of Neurocognitive and Psychiatric Disorders: Focusing on Transdiagnostic Approaches (Deadline: 29 February 2024)
- Regulatory T Cells in Neuroimmunological Disease Therapeutics (Deadline: 29 February 2024)
- Neuropathic Pain: Molecular Basis and Translational Research (Deadline: 29 February 2024)
- Advanced Research on Cerebrovascular Diseases (Deadline: 29 February 2024)
- Traumatic CNS Injury: From Bench to Bedside (Deadline: 29 February 2024)
- Molecular Mechanism of Amyloid Aggregation (Deadline: 29 February 2024)
- Neurocognitive Disorder: Diagnostic Methods, Treatment Challenges and Future Directions (Deadline: 29 February 2024)
- Genetic Research on Neurodevelopmental Disorders (Deadline: 29 February 2024)
- Synaptic Plasticity and Ion Transport in the Central Nervous System (CNS) (Deadline: 29 February 2024)
- Pathophysiological Mechanisms of Parkinson's Disease (Deadline: 29 February 2024)
- The Role of Amyloids in Neurodegenerative Diseases: Current Insights and Future Perspectives (Deadline: 29 February 2024)
- Oxidative Stress and Proteinopathy in Alzheimer's Disease (Deadline: 31 March 2024)
- Neurotrauma: Mechanisms, Pathways, and Emerging Therapeutic Interventions (Deadline: 31 March 2024)
- Neurodegenerative Diseases: Recent Advances and Future Perspectives (Deadline: 31 March 2024)
- Exploring Alpha-Synuclein’s Multifaceted Roles in Neurodegenerative Diseases: Novel Insights and Future Directions (Deadline: 31 March 2024)
- Encephalitis and Viral Infection: Mechanisms and Therapies (Deadline: 31 March 2024)
- Interplays between Metabolic Disorders and Neurological Diseases (Deadline: 30 April 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
